Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Blood|August 15, 1994
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host diseaseJ H Antin, H J Weinstein, E C Guinan, et al.
Bone Marrow Transplantation|December 23, 2015
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantationI Ahmad, R LeBlanc, S Cohen, et al.
Blood|June 17, 1998
Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution studyS Mach-Pascual, R D Legare, D Lu, et al.
Molecular and Cellular Biology|April 1, 1996
The t(12;21) translocation converts AML-1B from an activator to a repressor of transcriptionS W Hiebert, W Sun, J N Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemiaT R Golub, G F Barker, S K Bohlander, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Bone Marrow Transplantation|January 7, 1998
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasiaK K Ballen, D G Gilliland, E C Guinan, et al.
Leukemia|June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutationsA Pardanani, J Hood, T Lasho, et al.
Blood|June 5, 2001
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)J Schwaller, E Anastasiadou, D Cain, et al.
The EMBO Journal|September 16, 1998
Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genesJ Schwaller, J Frantsve, J Aster, et al.
Pageof 10